Prudential PLC Grows Position in Chemed Co. (NYSE:CHE)

Prudential PLC lifted its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 17.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,521 shares of the company's stock after purchasing an additional 528 shares during the period. Prudential PLC's holdings in Chemed were worth $1,865,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new position in Chemed in the 4th quarter worth approximately $95,872,000. Raymond James Financial Inc. purchased a new position in shares of Chemed during the 4th quarter worth approximately $42,023,000. Principal Financial Group Inc. raised its holdings in shares of Chemed by 114.1% in the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock valued at $39,554,000 after buying an additional 39,791 shares during the period. Segall Bryant & Hamill LLC purchased a new position in shares of Chemed in the fourth quarter valued at approximately $12,880,000. Finally, Boston Trust Walden Corp boosted its holdings in Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock valued at $128,303,000 after purchasing an additional 22,105 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 3.32% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several research firms have commented on CHE. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th.

Chemed Stock Performance

NYSE:CHE traded up $0.58 during trading hours on Friday, hitting $590.97. The company's stock had a trading volume of 16,028 shares, compared to its average volume of 96,683. The company has a market capitalization of $8.64 billion, a PE ratio of 29.81, a PEG ratio of 2.15 and a beta of 0.49. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $625.09. The business's 50-day moving average is $582.48 and its two-hundred day moving average is $567.97.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed's dividend payout ratio is currently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.